← Leaderboards
James L Rae
Mayo Clinic Coll Of Medicine, Rochester
$2,516,694
Attributed
$2,516,694
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,516,694 · 2
By mechanism
R01$2,516,694 · 2
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- William M Bourne$3,559,845
- David C Herman$313,411
- Richard F Brubaker$0
- Margaret M Redfield$19,467,646
- Richard A. Berger$677,059
Others in their field
Top investigators on “Potassium Channel”
- Mark T Nelson · University Of Vermont & St Agric College$22,792,389
- Leonard K Kaczmarek · Yale University$19,834,863
- Colin G Nichols · Washington University$19,232,207
- Christopher J Lingle · Washington University$17,330,812
- Amy F.t. Arnsten · Yale University$16,722,264
- James S Trimmer · State University New York Stony Brook$16,049,309
Research focus
Potassium ChannelLaboratory RabbitGreen Fluorescent ProteinsMembrane PermeabilityElectrophysiologyMembrane ChannelsMembrane Transport ProteinsMolecular CloningMuscarinic ReceptorPolymerase Chain ReactionProtein SequenceProtein Structure FunctionSodium ChannelCalcium ChannelTissue /Cell CultureHomeostasisChloride ChannelsHuman TissueCorneal EndotheliumIon TransportCorneal EpitheliumBiological Signal TransductionLaboratory RatAnura
Grant awards (7)
IONIC CHANNELS IN EPITHELIA OF THE EYE$383,285
R01 · FY2004 · EY
IONIC CHANNELS IN EPITHELIA OF THE EYE$374,788
R01 · FY2003 · EY
IONIC CHANNELS IN EPITHELIA OF THE EYE$364,748
R01 · FY2002 · EY
NORMAL AND CATARACTOUS LENS CELL BIOLECTRIC PROPERTIES$354,337
R01 · FY2002 · EY
IONIC CHANNELS IN EPITHELIA OF THE EYE$354,124
R01 · FY2001 · EY
NORMAL AND CATARACTOUS LENS CELL BIOLECTRIC PROPERTIES$346,507
R01 · FY2001 · EY
NORMAL AND CATARACTOUS LENS CELL BIOLECTRIC PROPERTIES$338,905
R01 · FY2000 · EY